HLB bioStep Co.,Ltd. (KOSDAQ:278650)

HLB bioStep Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 18, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	105,081	176,390	242,875	327,966	219,226	191,246
Market Cap Growth	-45.38%	-27.37%	-25.95%	49.60%	14.63%	27.19%
Enterprise Value	116,386	168,104	226,210	341,037	227,757	189,762
Last Close Price	1244.00	2095.00	3090.00	4650.00	3169.24	2756.75
PE Ratio	-	-	-	-	19.87	23.04
PS Ratio	1.47	3.03	4.60	3.80	3.40	3.27
PB Ratio	0.94	1.51	2.35	4.54	3.30	3.48
P/TBV Ratio	1.07	1.73	2.43	4.79	3.50	3.70
P/FCF Ratio	-	-	204.19	206.70	-	25.44
P/OCF Ratio	-	-	46.78	50.61	25.90	16.68
EV/Sales Ratio	1.63	2.89	4.28	3.95	3.54	3.24
EV/EBITDA Ratio	-	-	98.80	36.23	18.93	20.86
EV/EBIT Ratio	-	-	-	64.24	25.29	26.96
EV/FCF Ratio	-6.38	-	190.18	214.94	-	25.25
Debt / Equity Ratio	0.27	0.30	0.59	1.27	0.25	0.14
Debt / EBITDA Ratio	-	-	26.48	9.74	1.35	0.83
Debt / FCF Ratio	-	-	50.98	57.76	-	1.00
Net Debt / Equity Ratio	0.06	-0.10	-0.09	-0.07	0.09	-0.13
Net Debt / EBITDA Ratio	-1.12	1.46	-4.25	-0.58	0.49	-0.81
Net Debt / FCF Ratio	-0.39	0.59	-8.19	-3.42	-0.53	-0.98
Asset Turnover	0.44	0.34	0.31	0.65	0.76	0.86
Inventory Turnover	12.19	11.33	10.96	14.15	8.80	9.20
Quick Ratio	0.75	1.20	1.15	8.36	1.14	1.45
Current Ratio	1.29	1.35	1.23	8.57	1.75	1.86
Return on Equity (ROE)	-7.84%	-8.80%	-0.06%	-1.27%	19.00%	17.28%
Return on Assets (ROA)	-4.24%	-4.80%	-0.43%	2.49%	6.67%	6.48%
Return on Invested Capital (ROIC)	-9.71%	-13.15%	0.25%	7.64%	13.51%	15.45%
Return on Capital Employed (ROCE)	-9.40%	-10.70%	-1.10%	3.30%	11.50%	12.00%
Earnings Yield	-7.33%	-4.86%	-0.07%	-0.31%	5.03%	4.34%
FCF Yield	-17.36%	-11.68%	0.49%	0.48%	-5.08%	3.93%
Payout Ratio	-	-	-	-	10.26%	-
Buyback Yield / Dilution	8.09%	-11.80%	-9.59%	-0.02%	-1.35%	-13.51%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.